NL-OMON43787
Completed
Not Applicable
Right ventricle remodeling after pulmonary valve replacement and percutaneous pulmonary valve insertion, a functional and histopathological assessment. - RV-REPAIR
niversitair Medisch Centrum Utrecht0 sites40 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- congenital heart disease
- Sponsor
- niversitair Medisch Centrum Utrecht
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Grown\-up congenital heart disease patients with pulmonary insufficiency and/or stenosis and an indication for pulmonary valve replacement or percutaneous pulmonary valve insertion according to local GUCH team advise (based on current ESC GUCH guidelines). Also subjects who do not meet the indication criteria for valve replacement are eligible to participate in the study. They will form a conservative cohort.
Exclusion Criteria
- •\- Individual is younger than 18 years of age.
- •\- Individual has an estimated glomerular filtration rate (eGFR) of \<30mL/min/1\.73m2, using the MDRD calculation.
- •\- Individual has any serious medical condition, which in the opinion of the investigator, may adversely affect the safety and/or effectiveness of the participant or the study (i.e., patients with clinically significant peripheral vascular disease, abdominal aortic aneurysm, bleeding disorders such as thrombocytopenia, haemophilia, significant anaemia).
- •\- Individual is pregnant, nursing or planning to be pregnant.
- •\- Individual has a known, unresolved history of drug use or alcohol dependency, lacks the ability to comprehend or follow instructions, or would be unlikely or unable to comply with study follow\-up requirements.
- •\- Individual is currently enrolled in an investigational drug or device trial.
- •\- Individual with any contraindications for MRI:
- •a. The presence of implanted non\-MRI\-compatible cardiac pacemaker or implanted cardioverter defibrillator.
- •b. Implanted electronic devices like cochlear implants and nerve stimulators.
- •c. Patients who are unable to fit into the bore of the magnet.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Right Ventricle Remodeling After Pulmonary Valve Replacement and Percutaneous Pulmonary Valve InsertionEndomyocardial FibrosisPulmonary Valve StenosisPulmonary Valve InsufficiencyNCT05090228UMC Utrecht26
Active, not recruiting
Phase 1
Right ventriculAr reverse reModeling and hemodynamic improvement after add-on combination therapy (ambriSentan/PDE-5i) in PAH patientS (RAMSES)patients with pulmonary arterial hypertentionMedDRA version: 21.1Level: PTClassification code 10037400Term: Pulmonary hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2016-004806-32-ITITALIAN PULMONARY HYPERTENSION NETWORK, IPHNET54
Active, not recruiting
Not Applicable
eft ventricular reverse remodelling after aortic valve replacement in severe valvular aortic stenosis - effect of blockade of the angiotensin-II receptorPatients with severe aortic valve stenosis treated with Aortic Valve Replacement (AVR)EUCTR2005-001930-34-DKDepartment of Cardiology, Odense University Hospital
Completed
Not Applicable
Hemodynamic adaptation of the right ventricle in monochorionic twin pregnancies complicated by twin-to-twin transfusion syndrome or selective growth restrictioNL-OMON41328eids Universitair Medisch Centrum188
Not yet recruiting
Not Applicable
Improvement in Right Heart Chambers Dimensions After Closure of The Hole in the Heart Chamber Partition WallHealth Condition 1: Q211- Atrial septal defectCTRI/2024/04/065177AIIMS Delhi Research Section